The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists

被引:3
|
作者
Wang, Zhi-Peng [1 ]
Liu, Hui-Zhong [1 ]
Zhu, Liang [2 ]
Hu, You-Min [3 ]
Cui, Yong-Yao [2 ]
Niu, Yin-Yao [1 ]
Lu, Yang [1 ]
Chen, Hong-Zhuan [2 ]
机构
[1] Shanghai Jiao Tong Univ, Div Chem, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Div Pharmacol, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Funct Training Lab, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China
关键词
Tropane derivative; 6S Configuration; Muscarinic antagonist; Enantiomer; Subtype selectivity; MUSCLE;
D O I
10.1016/j.bmc.2012.12.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both enantiomers of 3 alpha-acyloxy-6 beta-acetoxyltropane derivatives 1-4 were prepared respectively and underwent functional studies and radioreceptor binding assays. 6S Enantiomers showed obvious muscarinic M3, M2 antagonistic activity, while the 6R ones elicited little muscarinic activity by functional studies. Besides, the affinity of 6S enantiomers to muscarinic M3 receptors of rat submandibulary gland, M2 receptors of rat left atria was much larger than that of corresponding 6R enantiomers. All these pharmalogical results indicated 6S configuration was favorable for 3 alpha-acyloxy-6 beta-acetoxyltropane derivatives to bind with muscarinic M3 or M2 receptors and elicited antagonistic activity. Furthermore, the muscarinic M3 activity and subtype selectivity (M3/M2) of 6S enantiomers could be improved by increasing the electron density of carbonyl oxygen or introducing methylene group between the carbonyl and phenyl ring in C-3 alpha position. Understanding the effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3 alpha-acyloxy-6 beta-acetoxyltropane derivatives will provide the clues for designing muscarinic M3 antagonists with high activity and low side effects or toxicity. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 50 条
  • [1] Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors
    Hou, VY
    Hirshman, CA
    Emala, CW
    ANESTHESIOLOGY, 1998, 88 (03) : 744 - 750
  • [2] J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors
    Mitsuya, M
    Mase, T
    Tsuchiya, Y
    Kawakami, K
    Hattori, H
    Kobayashi, K
    Ogino, Y
    Fujikawa, T
    Satoh, A
    Fujikawa, T
    Satoh, A
    Kimura, T
    Noguchi, K
    Ohtake, N
    Tomimoto, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2555 - 2567
  • [3] M2 AND M3 MUSCARINIC RECEPTOR EXPRESSION IN BLADDER TUMOR
    Asutay, Mehmet Kazim
    Aydin, Banu
    Toper, Hasan
    Filinte, Deniz
    Cabadak, Hulya
    Tinay, Ilker
    JOURNAL OF UROLOGY, 2018, 199 (04): : E778 - E778
  • [4] Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity
    Sagara, Yufu
    Sagara, Takeshi
    Uchiyama, Minaho
    Otsuki, Sachie
    Kimura, Toshifumi
    Fujikawa, Toru
    Noguchi, Kazuhito
    Ohtake, Norikazu
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (19) : 5653 - 5663
  • [5] Potential benefits of muscarinic M3 receptor selectivity
    Andersson, KE
    EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (04) : 23 - 28
  • [6] In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice
    Yamada, Shizuo
    Maruyama, Shuji
    Takagi, Yukiko
    Uchida, Shinya
    Oki, Tomomi
    LIFE SCIENCES, 2006, 80 (02) : 127 - 132
  • [7] The effect of muscarinic M3 receptor blockage in development of M2 macrophages in allergic inflammation
    Ohta, Shin
    Jinno, Megumi
    Tanaka, Akihiko
    Uno, Tomoki
    Uchida, Yoshitaka
    Manabe, Ryo
    Ida, Hitomi
    Kuwahara, Naota
    Fukuda, Yosuke
    Kimura, Tomoyuki
    Hirai, Kukniaki
    Miyata, Yoshito
    Yamaguchi, Munehiro
    Homma, Tetsuya
    Yamaguchi, Fumihiro
    Watanabe, Yoshio
    Suzuki, Shintaro
    Ohnishi, Tsukasa
    Sagara, Hironori
    Kusumoto, Sojiro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB293 - AB293
  • [8] Distribution of muscarinic receptor subtype M3 in melanomas and their metastases
    Oppitz, Matthias
    Busch, Christian
    Garbe, Claus
    Drews, Ulrich
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (09) : 809 - 815
  • [9] SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M3) RECEPTORS
    Broadley, Kenneth J.
    Davies, Robin H.
    Escargueil, Christine
    Lee, Alan T. L.
    Penson, Peter
    Thomas, Eric J.
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2011, 76 (07) : 781 - 801
  • [10] Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2
    Braverman, AS
    Ruggieri, MR
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (03) : R701 - R708